Is this you? Create Your Porfile
Avatar

Donna Johnstone

AstraZeneca

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Donna Johnstone is active.

Explore More

Publication

Featured researches published by Donna Johnstone.

Archive | 2003

5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist

Jon Owen Curwen; Andrew Hughes; Donna Johnstone; Clive Morris

Archive | 2003

N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent

David William Tonge; Sian Tomiko Taylor; Francis Thomas Boyle; Andrew Hughes; Donna Johnstone; Marianne Ashford; Nigel Charles Barrass

Archive | 2009

Use of n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide in the treatment of cancer

Marianne Ashford; Nigel Charles Barrass; Francis Thomas Boyle; Andrew Hughes; Donna Johnstone; Sian Tomiko Taylor; David William Tonge

Archive | 2005

Combination of N-(3-Methoxy-5-Methylpyrazin-2-Yl)-2-(4-[1,3,4-Oxadiazol-2-Yl]Phenyl)Pyridine-3-Sulphonamide and an Anti-Mitotic Cytotoxic Agent

John Curwen; Andrew Hughes; Donna Johnstone; Francis Thomas Boyle; Gwen Boyle

Archive | 2005

Combinaison de n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide et d'un agent cytotoxique anti-mitotique pour le traitement du cancer

Francis Thomas Boyle; John Curwen; Andrew Hughes; Donna Johnstone

Archive | 2003

Therapeutische behandlung Therapeutic treatment

Francis Thomas AstraZeneca Macclesfield Boyle; Jon Owen Curwen; Neil Gallagher; Ursula Joy AstraZeneca Macclesfield Hancox; Andrew Hughes; Donna Johnstone; Sian Tomiko Taylor; David William Tonge

Archive | 2003

Agonistes recepteurs de 5-ht 1b/1d utilises dans le traitement de maux de tete produits par l'administration d'un antagoniste recepteur d'endotheline

Jon Owen Curwen; Andrew Hughes; Donna Johnstone; Clive Morris

Archive | 2003

Use of N- (3-methoxy-5-methylpyrazin-2-yl) -2- (4-ä1,3,4-oxadiazol-2-ylüphenyl) pyridine-3-sulphonamide in tumor therapy

David William Tonge; Sian Tomiko Taylor; Francis Thomas Boyle; Andrew Hughes; Donna Johnstone; Marianne Ashford; Nigel Charles Barrass

Archive | 2003

N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3 sulfonamide as analgetic agent

Marianne Ashford; Nigel Charles Barrass; Francis Thomas Boyle; Andrew Hughes; Donna Johnstone; Sian Tomiko Taylor; David William Tonge

Archive | 2003

5-ht 1b/1d rezeptor agonisten zur behandlung von kopfschmerz der aus der verabreichung von endothelin rezeptor antagonisten resultiert

Jon Owen Curwen; Andrew Hughes; Donna Johnstone; Clive Morris

Explore More

Collaboration

Dive into the Donna Johnstone's collaboration.

Top Co-Authors
Avatar

Andrew Hughes

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Francis Thomas Boyle

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Jon Owen Curwen

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Clive Morris

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

David William Tonge

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Sian Tomiko Taylor

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Marianne Ashford

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Nigel Charles Barrass

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

John Curwen

AstraZeneca

View shared research outputs
Top Co-Authors
Avatar

Gwen Boyle

AstraZeneca

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge